The first fixed-dose combination pill containing 3 drugs has been approved for use in the United States by the US Food and Drug Administration (FDA). Exforge HCT®, which is marketed by Novartis, ...
Teva announced the launch of Amlodipine, Valsartan, and Hydrochlorothiazide Tablets, the generic version of Novartis‘ Exforge HCT. Exforge HCT contains amlodipine, a calcium channel blocker, valsartan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results